The Voluntary Improvement Program (VIP) is seen as a much-needed alternative channel to traditional audits and inspections, allowing device makers to obtain insight into global best practices and opportunities for quality improvement. In this whitepaper, developed as a summary of a webinar presented in September, learn how VIP adds value to the medical device industry beyond traditional continuous improvement initiatives.
VIP can serve as a valuable tool for streamlining operations, better understanding key performance indicators, implementing automation, and enhancing data management and communication
The Voluntary Improvement Program (VIP), supported by FDA as part of the agency’s Case for Quality Initiative, was developed in collaboration with the medical device industry, the Medical Device Innovation Consortium (MDIC), and MDDAP, LLC (a subsidiary of ISACA). This program identifies process inefficiencies and helps device makers implement best practices, as defined in a globally recognized maturity model, that accelerate medical device improvements.
Learn more.